Key Record Dates Identifier: NCT04052555
Brief Title: Testing the Addition of an Anti-cancer Drug, M6620, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative or Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer

First Submitted : August 8, 2019
First Submitted that Met QC Criteria : August 8, 2019
First Posted : August 12, 2019

Last Update Submitted that Met QC Criteria : October 4, 2019
Last Update Posted : October 7, 2019